Dianthus Therapeutics, Inc. /DE/ — Form 4
Filed August 11, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
Director McGeorge Anne (DNTH) sold 16K shares (~$845K) on the open market (96% of holdings). Large sale — ~96% of holdings.
Why this rating
Large sale — ~96% of holdings.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.